Caribbean News Now!

About Us Contact Us


Jump to your country or territory of interest

Advertise with us

Reach our daily visitors from around the Caribbean and throughout the world. Click here for rates and placements.


Submit news and opinion for publication


Click here to receive our daily regional news headlines by email.


Click here to browse our extensive archives going back to 2004

Also, for the convenience of our readers and the online community generally, we have reproduced the complete Caribbean Net News archives from 2004 to 2010 here.

Climate Change Watch

The Caribbean is especially vulnerable to rising sea levels brought about by global warming. Read the latest news and information here...

Follow Caribbean News Now on Twitter
Connect with Caribbean News Now on Linkedin

News from the Caribbean:

Back To Today's News

Cuban diabetic foot drug launches in new markets
Published on September 20, 2013 Email To Friend    Print Version

HAVANA, Cuba (ACN) -- Cuba’s Genetic Engineering and Biotechnology Centre will launch its diabetic foot ulcer pharmaceutical known as Heberprot-P into new markets, such as Brazil, Peru and some European countries.

Mailyin Palmero, a promotion official with the Havana centre, said that over 125,000 people have been treated with the Cuban drug in other countries, including nearly 100,000 Venezuelans.

The scientific institution is taking part at the 24th International Congress on Orthopedics and Traumatology, underway until Saturday at Havana’s Frank Pais orthopedic hospital.

The forum, which is being attended by local and foreign institutions in the field, offers an opportunity to promote the advantages of the Cuban pharmaceutical, which prevents the amputation of lower limbs in patients suffering from diabetic foot ulcers.

The commercialization of Heberprot-P is under negotiation in Brazil and Peru, while the medication is being submitted to clinical tests in Europe before its registration, said the official.

Palmero said that effectiveness studies reveal a successful 78 percent impact by the medication, though most of the people treated with it already suffered from advanced ulcers which, if their doctors had known about the drug before, the results would have been much better.

Heberprot-P was approved five years ago and over this period it has been commercialized in 18 countries, including Venezuela, Bolivia and Ecuador.
Reads: 6467

Click here to receive daily news headlines from Caribbean News Now!



No comments on this topic yet. Be the first one to submit a comment.


As a result of our comments feature being overtaken in recent weeks by spammers using fake email addresses, producing a large number of bounced verification emails each day, we have reluctantly decided to suspend the comments section until further notice.

User comments posted on this website are the sole views and opinions of the comment author and are not representative of Caribbean News Now or its staff. Caribbean News Now accepts no liability and will not be held accountable for user comments.
Caribbean News Now reserves the right to remove, edit or censor any comments. Any content that is considered unsuitable, unlawful or offensive, includes personal details, advertises or promotes products, services or websites or repeats previous comments will not be approved.
Before posting, please refer to our Terms of Use and Privacy Policy.

Other Headlines:

Regional Sports: